Infliximab therapy decreases the expression of serum and faecal miR-126 and miR-20a in paediatric Crohn's disease: A pilot study.

Marianna CasertanoMaria Consiglia TrottaSabrina CenniMara CreoliErasmo MieleMassimo MartinelliCaterina Claudia LepreMarina RussoRoberto AlfanoMichele D'AmicoCaterina Strusciuglio

Published in: Acta paediatrica (Oslo, Norway : 1992) (2023)

In children with CD, IFX therapy decreases the expression of serum and faecal miR-126 and miR-20a, suggesting an involvement of these two miRNAs in the action of the drug.

Keyphrases

long non coding rna
cell proliferation
poor prognosis
long noncoding rna
emergency department
intensive care unit
mesenchymal stem cells
ulcerative colitis
adverse drug